Deng T - Search Results

1

AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer.

Yin L, Ye Y, Zou L, Lin J, Dai Y, Fu Y, Liu Y, Peng Y, Gao Y, Fu Y, Qi X, Deng T, Zhang S, Li X. Yin L, et al. Among authors: deng t. J Exp Clin Cancer Res. 2023 Aug 10;42(1):204. doi: 10.1186/s13046-023-02776-0. J Exp Clin Cancer Res. 2023. PMID: 37563661 Free PMC article.

2

A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance.

Peng YB, Zhao ZL, Liu T, Xie GJ, Jin C, Deng TG, Sun Y, Li X, Hu XX, Zhang XB, Ye M, Tan WH. Peng YB, et al. Among authors: deng tg. ChemMedChem. 2017 Feb 3;12(3):250-256. doi: 10.1002/cmdc.201600538. Epub 2017 Jan 18. ChemMedChem. 2017. PMID: 28098432 Free PMC article.

3

Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer.

Deng T, Xiao Y, Dai Y, Xie L, Li X. Deng T, et al. Front Mol Biosci. 2021 Dec 15;8:743376. doi: 10.3389/fmolb.2021.743376. eCollection 2021. Front Mol Biosci. 2021. PMID: 34977151 Free PMC article. Review.

4

Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation-mediated CDC6 protein degradation.

Deng T, Zhu Q, Xie L, Liu Y, Peng Y, Yin L, Gao Y, Cao T, Fu Y, Qi X, Zhang S, Peng Y, Hou Y, Li X. Deng T, et al. Mol Carcinog. 2022 Aug;61(8):812-824. doi: 10.1002/mc.23435. Epub 2022 Jun 2. Mol Carcinog. 2022. PMID: 35652616

5

AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer.

Fu Y, Cao T, Zou X, Ye Y, Liu Y, Peng Y, Deng T, Yin L, Li X. Fu Y, et al. Among authors: deng t. Oncogenesis. 2023 Jan 2;12(1):1. doi: 10.1038/s41389-022-00446-y. Oncogenesis. 2023. PMID: 36593255 Free PMC article.

6

Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation.

Peng Y, Tang R, Ding L, Zheng R, Liu Y, Yin L, Fu Y, Deng T, Li X. Peng Y, et al. Among authors: deng t. Eur J Pharmacol. 2023 Mar 5;942:175522. doi: 10.1016/j.ejphar.2023.175522. Epub 2023 Jan 19. Eur J Pharmacol. 2023. PMID: 36681316 Free article.

7

ATM-Mediated translocation of RanBPM regulates DNA damage response by stabilizing p21 in non-small cell lung cancer cells.

Deng T, Xie L, Xiaofang C, Zhang Z, Xiao Y, Peng Y, Yin L, Fu Y, Li X. Deng T, et al. Cell Oncol (Dordr). 2024 Feb;47(1):245-258. doi: 10.1007/s13402-023-00866-x. Epub 2023 Sep 7. Cell Oncol (Dordr). 2024. PMID: 37676377 Free PMC article.

8

PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability.

Peng Y, Liu Y, Zheng R, Ye Y, Fu Y, Yin L, Gao Y, Fu Y, Qi X, Deng T, Zhang S, Li X. Peng Y, et al. Among authors: deng t. Cell Death Discov. 2023 Oct 3;9(1):367. doi: 10.1038/s41420-023-01667-9. Cell Death Discov. 2023. PMID: 37788997 Free PMC article.

9

SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability.

Peng Y, Qi X, Ding L, Huang J, Liu Y, Zheng R, Fu Y, Yin L, Deng T, Ye Y, Chen S, Li X. Peng Y, et al. Among authors: deng t. Br J Cancer. 2024 Nov 24. doi: 10.1038/s41416-024-02909-y. Online ahead of print. Br J Cancer. 2024. PMID: 39582087

10

Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro.

Chen X, Cai X, Zheng D, Huang X, Chen Y, Deng T, Mo L, Li H, Li J, Chen S. Chen X, et al. Among authors: deng t. Anticancer Drugs. 2022 Jan 1;33(1):e94-e102. doi: 10.1097/CAD.0000000000001147. Anticancer Drugs. 2022. PMID: 34261913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,095 results

Search Page

Filters